465 related articles for article (PubMed ID: 2931452)
1. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
[TBL] [Abstract][Full Text] [Related]
2. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
3. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study of immunophenotype of multiple myeloma cells].
Wang LL
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):286-8. PubMed ID: 8174466
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. B lymphocyte-associated antigens on terminal deoxynucleotidyl transferase-positive cells and pre-B cells in bone marrow of the rat.
Opstelten D; Deenen GJ; Rozing J; Hunt SV
J Immunol; 1986 Jul; 137(1):76-84. PubMed ID: 3086459
[TBL] [Abstract][Full Text] [Related]
7. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
8. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.
Hokland P; Ritz J; Schlossman SF; Nadler LM
J Immunol; 1985 Sep; 135(3):1746-51. PubMed ID: 3160778
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
Pilarski LM; Jensen GS
Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
11. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens.
Jackson N; Ling NR; Ball J; Bromidge E; Nathan PD; Franklin IM
Clin Exp Immunol; 1988 Jun; 72(3):351-6. PubMed ID: 3048803
[TBL] [Abstract][Full Text] [Related]
12. Markers of multiple hematopoietic-cell lineages in multiple myeloma.
Epstein J; Xiao HQ; He XY
N Engl J Med; 1990 Mar; 322(10):664-8. PubMed ID: 2137556
[TBL] [Abstract][Full Text] [Related]
13. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
14. Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.
Asma GE; van den Bergh RL; Vossen JM
Clin Exp Immunol; 1986 May; 64(2):356-63. PubMed ID: 3742878
[TBL] [Abstract][Full Text] [Related]
15. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
[TBL] [Abstract][Full Text] [Related]
16. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
17. No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma.
Duperray C; Bataille R; Boiron JM; Haagen IA; Cantaloube JF; Zhang XG; Boucheix C; Klein B
Cancer Res; 1991 Jun; 51(12):3224-8. PubMed ID: 1904006
[TBL] [Abstract][Full Text] [Related]
18. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
19. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
20. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
